Witte D P, Aronow B J, Harmony J A
Department of Pathology, Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
Pediatr Pathol Lab Med. 1996 Mar-Apr;16(2):173-94.
Cardiovascular malformations affect about 1% of newborns, yet much remains to be learned about the pathogenesis of these defects. Advances in understanding some of the molecular events involved in regulating cardiac morphogenesis are providing a new perspective with which to approach complex issues and questions related to congenital heart disease. More important, this new information provides not only unique opportunities for developing specific experimental models of congenital heart disease through direct genetic manipulation but also the basis for developing ways of therapeutically manipulating cardiac gene expression for some form of heart disease. This review presents recent advances in the understanding of the molecular aspects of cardiac development and how this information can be used to manipulate cardiac gene expression during development.
心血管畸形影响约1%的新生儿,但关于这些缺陷的发病机制仍有许多有待了解。在理解调节心脏形态发生的一些分子事件方面取得的进展,为处理与先天性心脏病相关的复杂问题提供了新的视角。更重要的是,这些新信息不仅为通过直接基因操作开发先天性心脏病的特定实验模型提供了独特机会,也为开发针对某种形式心脏病治疗性操纵心脏基因表达的方法奠定了基础。本综述介绍了在理解心脏发育分子方面的最新进展,以及如何利用这些信息在发育过程中操纵心脏基因表达。